RenovoRx Inc reports results for the quarter ended in June - Earnings Summary

RenovoRx

15/08/2024 15:26

* RenovoRx Inc  RNXT.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -31
cents.  The mean expectation of three analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -11 cents to -9 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * RenovoRx Inc's reported EPS for the quarter was a loss
of 10
cents​.
    * The company reported a quarterly loss of $2.39 million.
    * RenovoRx Inc shares had fallen by 0.9% this quarter and
lost 51.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for RenovoRx Inc is
$5.50 
This summary was machine generated from LSEG data August 15 at
02:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.10          -0.10          Met
 Mar. 31 2024      -0.14          -0.07          Beat
 Dec. 31 2023      -0.30          -0.31          Missed
 Sep. 30 2023      -0.30          -0.13          Beat